Physician profile
Rajan Arora
NPI 1861661845
$3,890.36
in general payments reported to CMS, 2019-2025
18 companies · $260 in 2025
The $260 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $716 · 2020: $357 · 2021: $690 · 2022: $827 · 2023: $458 · 2024: $582 · 2025: $260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,301.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,300.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $774.52 | 2022-2025 | Infuse, Ultra Multifocal Toric, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $751.24 | 2019-2021 | |
| Coopervision INC. | $678.65 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Alcon Vision LLC | $630.28 | 2019-2025 | Precision7, Dailies Total1, Total30 |
| Abb Con-Cise Optical Group LLC | $296.18 | 2021-2022 | |
| Johnson & Johnson Vision Care, INC. | $228.78 | 2020-2024 | |
| Glaukos Corporation | $168.57 | 2024 | Radius |
| Genzyme Corporation | $122.03 | 2019 | |
| Notal Vision, INC. | $86.26 | 2022 | |
| Sight Sciences, INC. | $33.57 | 2020 | |
| Allergan, INC. | $18.11 | 2021 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Novartis Pharmaceuticals Corporation | $16.19 | 2020 | |
| Eyevance Pharmaceuticals LLC | $14.91 | 2019 | |
| Abbvie INC. | $14.59 | 2023 | Lumigan, Vuity, Alphagan P |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $13.55 | 2022 | |
| Thea Pharma INC. | $13.10 | 2022 | |
| Maculogix, INC. | $12.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajan Arora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.